August 28, 2023
Irish drugmaker Mallinckrodt PLC filed its second Chapter 11 case in three years in an effort to erase about $1.9 billion of secured debt in a follow-up restructuring case that comes after its earlier Chapter 11 addressed its legacy opioid liability.